about
Evolution of naturally occurring 5'non-coding region variants of Hepatitis C virus in human populations of the South American regionInternational study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.Sensitive and specific detection of Trypanosoma cruzi DNA in clinical specimens using a multi-target real-time PCR approach.Immunological identification of Trypanosoma cruzi lineages in human infection along the endemic areaAnalytical performance of a multiplex Real-Time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples.Trypanosoma cruzi I genotypes in different geographical regions and transmission cycles based on a microsatellite motif of the intergenic spacer of spliced-leader genesMolecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina.Multiplex Real-Time PCR Assay Using TaqMan Probes for the Identification of Trypanosoma cruzi DTUs in Biological and Clinical Samples.Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of Chagas disease and discrimination of its clinical formsDifferent genotypes of Trypanosoma cruzi produce distinctive placental environment genetic response in chronic experimental infectionImpairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruziAnalytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease PatientsNew Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult PatientsSerological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern ArgentinaComparison of hepatitis C viral loads in patients with or without coinfection with different genotypesNew sylvatic hosts of Trypanosoma cruzi and their reservoir competence in the humid Chaco of Argentina: a longitudinal studyEvaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.Benznidazole treatment of chagasic encephalitis in pregnant woman with AIDS.Subtelomeric I-SceI-Mediated Double-Strand Breaks Are Repaired by Homologous Recombination in Trypanosoma cruzi.The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications.Urbanization of congenital transmission of Trypanosoma cruzi: prospective polymerase chain reaction study in pregnancy.Analytical sensitivity and specificity of a loop-mediated isothermal amplification (LAMP) kit prototype for detection of Trypanosoma cruzi DNA in human blood samples.Identification of Trypanosoma cruzi Discrete Typing Units (DTUs) in Latin-American migrants in Barcelona (Spain).Human Polymorphisms in Placentally Expressed Genes and Their Association With Susceptibility to Congenital Trypanosoma cruzi Infection.First report of a family outbreak of Chagas disease in French Guiana and posttreatment follow-up.Molecular diagnosis and treatment monitoring of congenital transmission of Trypanosoma cruzi to twins of a triplet delivery.Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction.Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi.Molecular diagnosis and typing of Trypanosoma cruzi populations and lineages in cerebral Chagas disease in a patient with AIDS.Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.Trypanozoma cruzi Infection in Patients Undergoing Solid Organ Transplantation.Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.Infestation of Mauritia flexuosa palms by triatomines (Hemiptera: Reduviidae), vectors of Trypanosoma cruzi and Trypanosoma rangeli in the Brazilian savanna.Interest and limitations of Spliced Leader Intergenic Region sequences for analyzing Trypanosoma cruzi I phylogenetic diversity in the Argentinean Chaco.New insights into Trypanosoma cruzi evolution, genotyping and molecular diagnostics from satellite DNA sequence analysis.Cloning and expression of transgenes using linear vectors in Trypanosoma cruzi.Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: A comparative study of sample treatments, DNA extraction methods and real-time PCR assays.High variability of Colombian Trypanosoma cruzi lineage I stocks as revealed by low-stringency single primer-PCR minicircle signatures.Alterations in Placental Gene Expression of Pregnant Women with Chronic Chagas Disease.
P50
Q27481052-5BFA77FF-F2A1-4C05-A94F-3562583E020CQ33802931-D21ED433-8AAA-4D37-A641-836E10AD1DD5Q34339762-24446EAF-E433-44E9-A2D3-F6BA801E56CBQ34422237-8D9C0A6D-E17D-4307-AC6D-5CF6EFC938B3Q34563636-6AAFC851-E60D-410D-B988-73B3BB09BB53Q34847171-EBD89328-7F12-4B41-B7E2-2A067FA54D0FQ35126958-2B8AB9FE-415F-49CC-BBC1-BF8130EBA4CCQ35624368-28053F27-222D-4DDA-B734-7CC62E2D09BCQ35652603-959EC3F0-93CE-413E-A38E-4C0031EBC75CQ36149620-3CA3248F-38BB-4CAA-B1C0-068CDD10CC69Q36300627-BDED0ACE-97C4-4B9E-ADDA-FC73409E5D36Q36422105-ABCB484D-8E91-4191-A0BA-1A9442157E5AQ36423574-13E9070C-7092-4809-B6C3-B6718BD1DB5AQ36571807-F6BEB020-69E3-40C8-8CD2-946D6873F2E8Q37007518-9502A80D-89E9-473B-B687-3A7CC78FF0C5Q37014659-D2701B48-C782-4A0E-BCB5-C4CD39A42949Q37119389-CC7E72E7-C231-46C6-A546-055C595701CAQ37124216-B9AF62B6-C2F0-4EF6-A70A-303D84596CC4Q37262422-C4EABA54-55C9-43F7-A632-2DE653D1321FQ37525486-2FE33B95-38A5-4DB6-9B85-AD30F4A819C2Q37973947-D61EDB45-96BC-4B05-8974-3F93894C62D8Q38910152-9910979A-6024-4374-B76A-26567853ABE1Q40126468-6C1D878A-4C85-4EF0-868C-132F4D947B02Q40414617-5A7D5ABF-250A-4A64-84B5-80F78F736470Q40898983-06335FA9-F338-4C8A-A4A2-D57B5CF5F9A5Q41635005-FA99061C-2E5C-48AB-A33B-A594A8C6CD04Q42630580-8F48BC5D-B833-4693-B872-1BE5DB1E92C1Q44548725-AEABE27B-598E-430A-922A-71C6F23CD88CQ44565648-C1F18374-8400-4C9D-8B30-18A75370A587Q46851382-6D6C086A-8DC8-4E9D-9314-65B2D2AD1EBAQ46922516-43C83C3C-8629-407C-AA08-F3B9CD439B01Q47104997-D46FDD60-7A79-4013-B703-0E68BBA178A9Q47708871-894CE31E-3D1E-4C61-B996-B25ACEDFA930Q48054922-04014A0C-C7AC-4E53-A934-8D7A15CB6F50Q48061491-7526AEA1-AE38-4BB9-9AB5-D68CA9DC2251Q48099243-F5D4F856-C38D-4F4D-A6EA-1E40C7C5A06AQ50668482-8BC1B03B-B33C-4CAD-A58D-87FF217EB567Q52583013-A0FB5371-6C49-4A14-8D62-C1B22716944BQ52674153-33E460F9-6734-40E9-93F9-75093BE9EB8DQ54255161-919987F4-8056-4FB0-B85A-AA11B9C45BF4
P50
name
Alejandro G Schijman
@ast
Alejandro G Schijman
@en
Alejandro G Schijman
@nl
type
label
Alejandro G Schijman
@ast
Alejandro G Schijman
@en
Alejandro G Schijman
@nl
prefLabel
Alejandro G Schijman
@ast
Alejandro G Schijman
@en
Alejandro G Schijman
@nl